Orasis Pharmaceuticals is an ophthalmic pharmaceutical company dedicated to advancing vision care through innovative solutions. The company is focused on the development and commercialization of Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4%, a novel eye drop designed to treat presbyopia in adults.
Leadership & Board
Current Number of Employees68
Current LinkedIn Followers8,243
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$78M
Total Amount Raised$78M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$78M
Latest Funding Amount$78M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Orasis Pharmaceuticals had 68 employees as of September 28, 2026. The number of employees increased by 1 (1.49%) week-over-week.
68Latest Employee Count
1(1.49%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Orasis Pharmaceuticals had 8,243 followers as of September 28, 2026. The number of followers decreased by 6 (0.07%) week-over-week.
8,243Latest Followers Count
6(-0.07%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.